公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer | Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU ; Guo C.-L.; Chang G.-C.; Li K.-C.; CHAO-CHI HO ; HUEI-WEN CHEN | Cancer Immunology, Immunotherapy | 23 | 23 | |
2016 | Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women | Wang Z.; Seow W.-J.; Shiraishi K.; Hsiung C.A.; Matsuo K.; Liu J.; Chen K.; Yamji T.; Yang Y.; Chang I.-S.; Wu C.; Ho J.C.M.; Chan J.K.C.; Wang J.-C.; Lu D.; Zhao X.; Zhao Z.; Wu J.; Chen H.; Jin L.; Wei F.; Hong Y.-C.; Wu G.; An S.-J.; Zhang X.-C.; Su J.; Wu Y.-L.; Gao Y.-T.; Xiang Y.-B.; He X.; Li J.; Zheng W.; Burdett L.; Shu X.-O.; Cai Q.; Klein R.; Pao W.; Lawrence C.; Hosgood H.D.; III, Hsiao C.-F.; Chien L.-H.; Chen Y.-H.; Chen C.-H.; Wyatt K.; Wang W.-C.; Chen C.-Y.; Wang C.-L.; CHONG-JEN YU ; Chen H.-L.; Su Y.-C.; Tsai F.-Y.; Chen Y.-S.; Li Y.-J.; Yang T.-Y.; Chung C.C.; Lin C.-C.; PAN-CHYR YANG ; Wu T.; Lin D.; Zhou B.; Yu J.; Shen H.; Kubo M.; Chanock S.J.; Rothman N.; Li S.A.; Lan Q.; Yeager M.; Hutchinson A.; Hu W.; Caporaso N.; Landi M.T.; Chatterjee N.; Song M.; Fraumeni J.F.; Jr.; Kohno T.; Yokota J.; Kunitoh H.; Ashikawa K.; Momozawa Y.; Daigo Y.; Mitsudomi T.; Yatabe Y.; Hida T.; Hu Z.; Dai J.; Ma H.; Jin G.; Song B.; Wang Z.; Cheng S.; Yin Z.; Li X.; Ren Y.; Guan P.; Chang J.; Tan W.; Chen C.-J.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; KUAN-YU CHEN ; Huang M.-S.; Chen Y.-M.; Zheng H.; Li H.; Cui P.; Guo H.; Xu P.; Liu L.; Iwasaki M.; Shimazu T.; Tsugane S.; Zhu J.; Jiang G.; Fei K.; Park J.Y.; Kim Y.H.; Sung J.S.; Park K.H.; Kim Y.T.; Jung Y.J.; Kang C.H.; Park I.K.; Kim H.N.; Jeon H.-S.; Choi J.E.; Choi Y.Y.; Kim J.H.; Oh I.-J.; Kim Y.-C.; Sung S.W.; Kim J.S.; Yoon H.-I.; Kweon S.-S.; Shin M.-H.; Seow A.; Chen Y.; Lim W.-Y.; Liu J.; Wong M.P.; Lee V.H.F.; Bassig B.A.; Tucker M.; Berndt S.I.; Chow W.-H.; Ji B.-T.; Wang J.; Xu J.; Sihoe A.D.L. | Human Molecular Genetics | 43 | 34 | |
2008 | MicroRNA Signature Predicts Survival and Relapse in Lung Cancer | SUNG-LIANG YU ; HSUAN-YU CHEN; Chang G.-C.; Chen C.-Y.; HUEI-WEN CHEN ; Singh S.; Cheng C.-L.; CHONG-JEN YU ; Lee Y.-C.; Chen H.-S.; Su T.-J.; Chiang C.-C.; Li H.-N.; Hong Q.-S.; Su H.-Y.; Chen C.-C.; Chen, W.-J.; Liu C.-C.; Chan W.-K.; WEI J. CHEN ; Li K.-C.; Chen J.J.W.; PAN-CHYR YANG | Cancer Cell | 725 | 672 | |
2016 | Molecular gene signature and prognosis of non-small cell lung cancer | Huang P.; Cheng C.-L.; Chang Y.-H.; Liu C.-H.; Hsu Y.-C.; JIN-SHING CHEN ; Chang G.-C.; Ho B.-C.; KANG-YI SU ; Chen H.-Y.; SUNG-LIANG YU | Oncotarget | 17 | 16 | |
2013 | The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma | Hung P.-F.; Hong T.-M.; Hsu Y.-C.; Chen H.-Y.; YIH-LEONG CHANG ; CHEN-TU WU ; Chang G.-C.; Jou Y.-S.; SZU-HUA PAN ; PAN-CHYR YANG | PLoS ONE | 35 | 31 | |
2018 | Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma | KANG-YI SU ; Tseng J.-S.; Liao K.-M.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang G.-C. | PLoS ONE | 17 | 13 | |
1997 | A neuro-control system for the knee joint position control with quadriceps stimulation | Chang G.-C.; JER-JUNN LUH ; Liao G.-D.; Lai J.-S.; Cheng C.-K.; Kuo B.-L.; Kuo T.-S. | IEEE Transactions on Rehabilitation Engineering | 103 | 0 | |
2006 | A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma | Tsai M.-F.; Wang C.-C.; Chang G.-C.; Chen C.-Y.; Chen H.-Y.; Cheng C.-L.; Yang Y.-P.; Wu C.-Y.; Shih F.-Y.; Liu C.-C.; Lin H.-P.; Jou Y.-S.; Lin S.-C.; CHUNG-WU LIN ; WEI J. CHEN ; Chan W.-K.; Chen J.J.W.; PAN-CHYR YANG | Journal of the National Cancer Institute | 101 | 98 | |
2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; CHIH-HSIN YANG ; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO ; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | 8 | 5 | |
2022 | An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study | Su P.-L.; Chang G.-C.; Hsiao S.-H.; Hsia T.-C.; Lin M.-C.; Lin M.-H.; JIN-YUAN SHIH ; Yang C.-T.; Yang S.-H.; Chen Y.-M. | JTO Clinical and Research Reports | 2 | 0 | |
2016 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma | Su T.-J.; Ku W.-H.; Chen H.-Y.; Hsu Y.-C.; Hong Q.-S.; Chang G.-C.; SUNG-LIANG YU ; Chen J.J.W. | American Journal of Cancer Research | 22 | | |
2016 | Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition | Lin S.-Y.; Lee Y.-X.; SUNG-LIANG YU ; Chang G.-C.; Chen J.J.W. | Oncotarget | 7 | 7 | |
2009 | A polymorphism in the APE1 gene promoter is associated with lung cancer risk | Lo Y.-L.; Jou Y.-S.; Hsiao C.-F.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; KUAN-YU CHEN ; Chen Y.-M.; Huang M.-S.; Chi Y.H.; Chen C.-J.; Hsiung C.A. | Cancer Epidemiology Biomarkers and Prevention | 74 | 71 | |
2011 | Polymorphisms of MLH1 and MSH2 genes and the risk of lung cancer among never smokers | Lo Y.-L.; Hsiao C.-F.; Jou Y.-S.; Chang G.-C.; Tsai Y.-H.; Su W.-C.; KUAN-YU CHEN ; Chen Y.-M.; Huang M.-S.; Hsieh W.-S.; Chen C.-J.; Hsiung C.A. | Lung Cancer | 53 | 50 | |
2017 | Predictive factors for EGFR-tyrosine kinase inhibitor retreatment in patients with EGFR-mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study | Chang G.-C.; Tseng C.-H.; Hsu K.-H.; CHONG-JEN YU ; Yang C.-T.; Chen K.-C.; Yang T.-Y.; Tseng J.-S.; Liu C.-Y.; WEI-YU LIAO ; Hsia T.-C.; Tu C.-Y.; Lin M.-C.; Tsai Y.-H.; Hsieh M.-J.; Wu W.-S.; Chen Y.-M. | Lung Cancer | 22 | 18 | |
2006 | Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients | Chang G.-C.; Tsai C.-M.; Chen K.-C.; CHONG-JEN YU ; JIN-YUAN SHIH ; Yang T.-Y.; Lin C.-P.; Hsu J.-Y.; Chiu C.-H.; Perng R.-P.; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
2016 | Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; KANG-YI SU ; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; SUNG-LIANG YU ; HUEI-WEN CHEN ; Yang T.-Y.; Chang G.-C. | Journal of Thoracic Disease | 2 | 2 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 464 | 428 | |
2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C. | Journal of Clinical Oncology | 76 | 71 | |
2019 | Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial | Nakagawa K.; Garon E.B.; Seto T.; Nishio M.; Ponce Aix S.; Paz-Ares L.; Chiu C.-H.; Park K.; Novello S.; Nadal E.; Imamura F.; Yoh K.; JIN-YUAN SHIH ; Au K.H.; Moro-Sibilot D.; Enatsu S.; Zimmermann A.; Frimodt-Moller B.; Visseren-Grul C.; Reck M.; Chu Q.; Cortot A.; Pujol J.-L.; Fabre E.; Lamour C.; Bischoff H.; Kollmeier J.; Kimmich M.; Engel-Riedel W.; Hammerschmidt S.; Schütte W.; Syrigos K.; Ho J.C.M.; Au K.-H.; Ardizzoni A.; Pasello G.; Gregorc V.; Del Conte A.; Galetta D.; Takahashi T.; Kumagai T.; Hotta K.; Goto Y.; Hosomi Y.; Sakai H.; Takiguchi Y.; Kim Y.H.; Kurata T.; Yamaguchi H.; Daga H.; Okamoto I.; Satouchi M.; Ikeda S.; Kasahara K.; Atagi S.; Azuma K.; Aoe K.; Horio Y.; Yamamoto N.; Tanaka H.; Watanabe S.; Nogami N.; Ozaki T.; Koyama R.; Hirashima T.; Kaneda H.; Tomii K.; Fujita Y.; Seike M.; Nishimura N.; Kato T.; Ichiki M.; Saka H.; Hirano K.; Nakahara Y.; Sugawara S.; Kim S.-W.; Min Y.J.; Lee H.W.; Kang J.-H.; An H.J.; Lee K.H.; Kim J.-S.; Lee G.-W.; Lee S.Y.; Alexandru A.; Udrea A.A.; Juan-Vidal Ó.; Nadal-Alforja E.; Gil-Bazo I.; Ponce-Aix S.; Rubio-Viqueira B.; Alonso Garcia M.; Felip Font E.; Fuentes Pradera J.; Coves Sarto J.; Lin M.-C.; Su W.-C.; Hsia T.-C.; Chang G.-C.; Wei Y.-F.; Su J.; Cicin I.; Goksel T.; Harputluoglu H.; Ozyilkan O.; Henning I.; Popat S.; Hatcher O.; Mileham K.; Acoba J.; Garon E.; Jung G.; Raj M.; Martin W.; Dakhil S. | The Lancet Oncology | 397 | 341 | |